Powered by

Ginkgo Bioworks Funds Expansion of Rapid Antigen Test Manufacturing with Access Bio in New Jersey; Securing access to 10 million rapid antigen tests, which are EUA authorized and available today through Concentric by Ginkgo

Nov 20, 2020 - PR Newswire

PR Newswire

 Today, Ginkgo Bioworks announced it has secured access to at least 10 million rapid antigen test kits from Access Bio, a global in vitro diagnostics company. The tests will be available through Concentric by Ginkgo, the company's end-to-end service for COVID-19 testing, for organizations seeking to use testing as part of their broader public health strategies. Additionally, Ginkgo provided capital to expand manufacturing capacity at Access Bio's New Jersey factory for product...